跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAONIL 5mg Tablets - TGA Drug Approval Details
Approvals
/
TGA
/
DAONIL 5mg Tablets
Approved
STANDARD
DAONIL 5mg Tablets
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
e6884f0d210b9a3e
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e6884f0d210b9a3e
Product Name
DAONIL 5mg Tablets
Artg Id
73683
Artg Name
DAONIL glibenclamide 5mg tablet blister pack
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2000-04-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7c38ac2a42b0a98a288f0f602a526d14.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/57f26d1c23b717d7be891ab92cfa3c10.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
e6884f0d210b9a3e
Type
Standard
Back to TGA Approvals